Effect analysis of pharmacists' standardized prescription management of proprotein convertase subtilis/Kexin type 9 inhibitors based on PDCA cycle management

Zhao Qiang; Liu Xinyu; Sun Yahong; Jia Na; Shi Jia; Zhou Yang; Shi Xiujin; Qiu Qi; Lin Yang

doi:10.3760/j.issn.1673-4777.2023.03.017

Home>Articles>Effect analysis of pharmacists' standardized prescription management of proprotein convertase subtilis/Kexin type 9 inhibitors based on PDCA cycle management

DOI: 10.3760/j.issn.1673-4777.2023.03.017

Effect analysis of pharmacists' standardized prescription management of proprotein convertase subtilis/Kexin type 9 inhibitors based on PDCA cycle management

Zhao Qiang

Liu Xinyu

Sun Yahong

Jia Na

Shi Jia

Zhou Yang

Shi Xiujin

Qiu Qi

Lin Yang

Machine-generated Keywords：

Publication Date：2023-03-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 400-404 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2023,18(3)